These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1101714)
21. Minimal brain dysfunction/specific learning disability: a clinical approach for the primary physician. Levy HB South Med J; 1976 May; 69(5):642-53. PubMed ID: 1273628 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive management of the hyperkinetic child. Renshaw D Aust Fam Physician; 1976 Oct; 5(9):1289-90, 1293-4, 1297 passim. PubMed ID: 1008743 [TBL] [Abstract][Full Text] [Related]
24. Dextroamphetamine and methylphenidate in the treatment of hyperactive-aggressive children. Winsberg BG; Press M; Bialer I; Kupietz S Pediatrics; 1974 Feb; 53(2):236-41. PubMed ID: 4590730 [No Abstract] [Full Text] [Related]
25. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936 [TBL] [Abstract][Full Text] [Related]
26. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Ashwal S; Russman BS; Blasco PA; Miller G; Sandler A; Shevell M; Stevenson R; ; Neurology; 2004 Mar; 62(6):851-63. PubMed ID: 15037681 [TBL] [Abstract][Full Text] [Related]
27. [Special schooling, education counseling psychotherapy and pharmacotherapy in children with minimal brain damage]. Weber A Ther Umsch; 1977 Jan; 34(1):24-8. PubMed ID: 841506 [No Abstract] [Full Text] [Related]
28. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome. Gross MD Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283 [No Abstract] [Full Text] [Related]
29. The hyperkinetic child: current status. Dubey DR Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561 [No Abstract] [Full Text] [Related]
30. Psychosocial treatments for attention-deficit/hyperactivity disorder in children. Barkley RA J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060 [TBL] [Abstract][Full Text] [Related]
32. Genetic issues in the syndrome of minimal brain dysfunction. Omenn GS Semin Psychiatry; 1973 Feb; 5(1):5-17. PubMed ID: 4610759 [No Abstract] [Full Text] [Related]
33. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. Arnold LE; Christopher J; Huestis R; Smeltzer DJ Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123 [TBL] [Abstract][Full Text] [Related]
34. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Nolan EE; Gadow KD; Sprafkin J Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294 [TBL] [Abstract][Full Text] [Related]
35. Drugs in management of minimal brain dysfunction. Millichap JG Ann N Y Acad Sci; 1973 Feb; 205():321-34. PubMed ID: 4144050 [No Abstract] [Full Text] [Related]
36. Methylphenidate: a review. Oettinger L; Majovski LV South Med J; 1976 Feb; 69(2):161-3. PubMed ID: 1251235 [TBL] [Abstract][Full Text] [Related]